Your browser doesn't support javascript.
loading
Respiratory syncytial virus-neutralizing serum antibody titers in infants following palivizumab prophylaxis with an abbreviated dosing regimen.
Claydon, Jennifer; Sur, Amitava; Callejas, Allison; Ladd, Mihoko; Kwan, Eddie; Taylor, Richard; Turvey, Stuart E; Solimano, Alfonso; Lavoie, Pascal M; Marr, Nico.
Afiliación
  • Claydon J; Department of Pediatrics, University of British Columbia, Vancouver, Canada.
  • Sur A; BC Children's Hospital Research Institute, Vancouver, Canada.
  • Callejas A; Children's & Women's Health Centre of British Columbia, Vancouver, Canada.
  • Ladd M; Children's & Women's Health Centre of British Columbia, Vancouver, Canada.
  • Kwan E; Department of Pediatrics, University of British Columbia, Vancouver, Canada.
  • Taylor R; BC Children's Hospital Research Institute, Vancouver, Canada.
  • Turvey SE; Children's & Women's Health Centre of British Columbia, Vancouver, Canada.
  • Solimano A; Department of Pediatrics, University of Victoria, Victoria, Canada.
  • Lavoie PM; Department of Pediatrics, University of British Columbia, Vancouver, Canada.
  • Marr N; BC Children's Hospital Research Institute, Vancouver, Canada.
PLoS One ; 12(4): e0176152, 2017.
Article en En | MEDLINE | ID: mdl-28437470
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Virus Sincitial Respiratorio Humano / Infecciones por Virus Sincitial Respiratorio / Anticuerpos Neutralizantes / Palivizumab / Anticuerpos Antivirales Límite: Female / Humans / Infant / Male Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Virus Sincitial Respiratorio Humano / Infecciones por Virus Sincitial Respiratorio / Anticuerpos Neutralizantes / Palivizumab / Anticuerpos Antivirales Límite: Female / Humans / Infant / Male Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: Canadá